Colloidal Silver Research

At the turn of the 20th century, scientists made a groundbreaking discovery: the body’s most important fluids, such as blood, are colloidal in nature. These fluids consist of ultra-fine particles suspended in liquid, a characteristic that allows them to carry essential nutrients and oxygen to the body’s cells. This discovery sparked early interest in colloidal silver, leading to its use as a mainstream antibiotic treatment by physicians prior to 1938. Colloidal silver was considered a “high-tech” medical innovation at the time. However, the production methods for colloidal silver were expensive, which led to the rise of the pharmaceutical industry and the development of faster-acting, more toxic drugs. As a result, colloidal silver research was sidelined in favor of these new treatments. The U.S. Food and Drug Administration (FDA) now classifies colloidal silver as a pre-1938 drug, with a letter dated September 13, 1991, stating: “These products may continue to be marketed… as long as they are advertised and labelled for the same use as in 1938 and as long as they are manufactured in the original manner.” Some of the traditional manufacturing methods used before 1938, including the electro-colloidal process, are still in use today and are known to be the most effective method for producing colloidal silver.

In the late 1970s, while researching the regeneration of limbs and spinal cords, Dr. Robert O. Becker, author of The Body Electric, made a remarkable discovery: silver ions not only promote bone growth but also help to kill surrounding bacteria. This breakthrough set the stage for renewed interest in silver’s medicinal properties. In March 1978, Science Digest published an article titled “Our Mightiest Germ Fighter,” which reported: “Thanks to eye-opening research, silver is emerging as a wonder of modern medicine. An antibiotic kills perhaps a half-dozen different disease organisms, but silver kills over 650. Resistant strains fail to develop. Moreover, silver is virtually non-toxic.” Dr. Harry Margraf, a biochemist and pioneering silver researcher, worked alongside the late Dr. Carl Moyer, Chairman of Washington University’s Department of Surgery in the 1970s. Dr. Margraf’s research confirmed that silver is an incredibly effective antimicrobial agent, with a broad spectrum of action. He famously said, “Silver is the best all-around germ fighter we have.”